DE69426979T2 - Verfahren zur herstellung von hiv-proteasehemmern - Google Patents

Verfahren zur herstellung von hiv-proteasehemmern

Info

Publication number
DE69426979T2
DE69426979T2 DE69426979T DE69426979T DE69426979T2 DE 69426979 T2 DE69426979 T2 DE 69426979T2 DE 69426979 T DE69426979 T DE 69426979T DE 69426979 T DE69426979 T DE 69426979T DE 69426979 T2 DE69426979 T2 DE 69426979T2
Authority
DE
Germany
Prior art keywords
hiv protease
protease inhibitors
producing hiv
intermediates
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69426979T
Other languages
English (en)
Other versions
DE69426979D1 (de
Inventor
David Askin
P Volante
K Eng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/187,664 external-priority patent/US5463067A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE69426979D1 publication Critical patent/DE69426979D1/de
Application granted granted Critical
Publication of DE69426979T2 publication Critical patent/DE69426979T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
DE69426979T 1993-07-16 1994-07-11 Verfahren zur herstellung von hiv-proteasehemmern Expired - Lifetime DE69426979T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9322593A 1993-07-16 1993-07-16
US08/187,664 US5463067A (en) 1993-07-16 1994-01-26 Process for making HIV protease inhibitors
PCT/US1994/007706 WO1995002584A2 (en) 1993-07-16 1994-07-11 Process for making hiv protease inhibitors

Publications (2)

Publication Number Publication Date
DE69426979D1 DE69426979D1 (de) 2001-05-03
DE69426979T2 true DE69426979T2 (de) 2001-09-20

Family

ID=26787287

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69426979T Expired - Lifetime DE69426979T2 (de) 1993-07-16 1994-07-11 Verfahren zur herstellung von hiv-proteasehemmern

Country Status (22)

Country Link
US (2) US5491238A (de)
EP (1) EP0708762B1 (de)
JP (1) JP3547136B2 (de)
CN (2) CN1066723C (de)
AT (1) ATE200079T1 (de)
AU (1) AU676079B2 (de)
CZ (1) CZ293953B6 (de)
DE (1) DE69426979T2 (de)
DK (1) DK0708762T3 (de)
ES (1) ES2155091T3 (de)
FI (1) FI119473B (de)
GR (1) GR3035645T3 (de)
HU (1) HUT74583A (de)
IL (1) IL110342A (de)
LV (1) LV12825B (de)
NO (1) NO306297B1 (de)
NZ (1) NZ269904A (de)
PL (1) PL179039B1 (de)
PT (1) PT708762E (de)
RU (1) RU2125561C1 (de)
SK (1) SK282616B6 (de)
WO (1) WO1995002584A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110255A (en) * 1993-07-16 1998-12-06 Merck & Co Inc Creation and resolution of 2 tert-butylcarboxamidopiprazine
IL111584A0 (en) * 1993-11-18 1995-01-24 Merck & Co Inc Prodrugs of an inhibitor of hiv protease and pharmaceutical compositions containing them
ATE163642T1 (de) * 1994-11-04 1998-03-15 Yamakawa Chemical Ind Verfahren zur herstellung von optisch aktiven piperazinderivaten und zwischenprodukten für ihre herstellung
DE4446025A1 (de) * 1994-12-22 1996-06-27 Basf Ag 2-Caroxamido-1,4,5,6-tetrahydropyrazine
EP1125930A1 (de) * 1995-05-23 2001-08-22 Lonza Ag Optisch aktive 2-Piperazincarbonsäurederivate und Verfahren zu ihrer Herstellung
DE59608234D1 (de) * 1995-05-23 2002-01-03 Lonza Ag Verfahren zur Herstellung von optisch aktiven 2-Piperazincarbonsäurederivaten
CA2201218C (en) * 1996-04-23 2004-09-28 Rudolf Fuchs Process for the preparation of optically active piperazine-2-carboxylic acid derivatives
US6645961B1 (en) 1997-03-07 2003-11-11 Merck & Co., Inc. Dry granulation formulation for an HIV protease inhibitor
US6482952B2 (en) 2000-06-20 2002-11-19 Merck & Co., Inc. Process for preparing acetonides
US7218837B2 (en) 2000-09-25 2007-05-15 Victor Company Of Japan, Ltd. Program-signal recording and reproducing apparatus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2052907A1 (en) * 1990-10-11 1992-04-12 Joseph P. Vacca Hiv protease inhibitors having symmetrical structure
US5169952A (en) * 1991-07-02 1992-12-08 Merck & Co., Inc. Stereoselective production of hydroxyamide compounds from chiral α-amino epoxides
CA2072237A1 (en) * 1991-07-02 1993-01-03 Merck & Co., Inc. Stereoselective production of hydroxyamide compounds from chiral –-amino epoxides

Also Published As

Publication number Publication date
DE69426979D1 (de) 2001-05-03
PL312613A1 (en) 1996-04-29
IL110342A0 (en) 1994-10-21
NO306297B1 (no) 1999-10-18
NO960168D0 (no) 1996-01-15
US5491238A (en) 1996-02-13
PT708762E (pt) 2001-07-31
CN1252402A (zh) 2000-05-10
CN1130380A (zh) 1996-09-04
CN1066723C (zh) 2001-06-06
RU2125561C1 (ru) 1999-01-27
CZ13196A3 (en) 1996-04-17
FI960184A (fi) 1996-03-14
WO1995002584A3 (en) 1995-03-09
CZ293953B6 (cs) 2004-08-18
GR3035645T3 (en) 2001-06-29
DK0708762T3 (da) 2001-04-30
HUT74583A (en) 1997-01-28
LV12825B (en) 2002-09-20
SK5596A3 (en) 1997-01-08
JPH08509985A (ja) 1996-10-22
IL110342A (en) 1998-12-27
FI119473B (fi) 2008-11-28
PL179039B1 (pl) 2000-07-31
CN1192014C (zh) 2005-03-09
HU9600077D0 (en) 1996-03-28
ES2155091T3 (es) 2001-05-01
ATE200079T1 (de) 2001-04-15
US5496948A (en) 1996-03-05
EP0708762A1 (de) 1996-05-01
FI960184A0 (fi) 1996-01-15
EP0708762B1 (de) 2001-03-28
AU676079B2 (en) 1997-02-27
SK282616B6 (sk) 2002-10-08
NO960168L (no) 1996-03-15
JP3547136B2 (ja) 2004-07-28
NZ269904A (en) 1997-11-24
LV12825A (en) 2002-05-20
WO1995002584A2 (en) 1995-01-26
AU7358894A (en) 1995-02-13

Similar Documents

Publication Publication Date Title
ATE153332T1 (de) Verfahren zur herstellung von oxetanonen
ATE241998T1 (de) Multikatalytische protease-inhibitoren
DE69426979T2 (de) Verfahren zur herstellung von hiv-proteasehemmern
ATE132487T1 (de) Verfahren zur herstellung von substituierten piperidinen
ATE158579T1 (de) Verfahren zur herstellung von (3r,5s)6-hydroxy- 3,5-0-isopropyliden-3,5-dihydroxy-hexansäure- tert.-butylester
DE69432176D1 (de) Verfahren zur herstellung von hiv protease inhibitoren
ATE206407T1 (de) Verfahren zur herstellung von hiv proteasinhibitoren
ATE180783T1 (de) Verfahren zur herstellung von ergolin derivaten
DE69431824D1 (de) Verfahren zur Herstellung von Schwefelhaltigen Imidazolderivaten und erhaltene Zwischenprodukte
ATE244224T1 (de) Verfahren zur umwandlung von 2,4-dichlorpyridinen in 2-aryloxy-4-chlorpyridine
DK0643055T3 (da) Fremgangsmåde til fremstilling af 5-amino-2,2-dialkyl-1,3-dioxaner
DE69619402T2 (de) Verfahren zur herstellung von methoximinophenylglyoxylsäure-derivaten
DE69810924T2 (de) Verfahren zur herstellung von arylmalonaten
ATE16381T1 (de) Verfahren zur herstellung von alpha-alkylaminoaldehyden.
DE69416117D1 (de) Verfahren zur herstellung von kondensierten carbapenemderivaten
FI944967A (fi) Menetelmiä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten ja niiden välituotteiden valmistamiseksi
IT1270834B (it) Disolfuro chinolico
DE60306506D1 (de) Verfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERCK SHARP & DOHME CORP., NEW JERSEY, N.J., US